Lexicon Pharmaceuticals LXRX Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's net change in cash?
- Lexicon Pharmaceuticals (LXRX) reported net change in cash of $3.76M in Q1 2026.
- How has Lexicon Pharmaceuticals's net change in cash changed year-over-year?
- Lexicon Pharmaceuticals's net change in cash increased by 199.9% year-over-year, from -$3.77M to $3.76M.
- What is the long-term trend for Lexicon Pharmaceuticals's net change in cash?
- Over 2 years (2021 to 2025), Lexicon Pharmaceuticals's net change in cash has grown at a -77.3% compound annual growth rate (CAGR), from -$64.43M to -$3.33M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.